Transient immune blockade prevents formation of neutralizing antibody to recombinant adenovirus and allows repeated gene transfer to mouse liver

Gene Therapy

Volumn 3, Issue 5, 1996, Pages 412-420

  Yang, Y ^a   Greenough, K ^a   Wilson, J M ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

Adenoviral vectors; CD4+ T lymphocytes; Gene therapy; IL 12; Immune responses

Indexed keywords

CAPSID PROTEIN; CD4 ANTIGEN; INTERLEUKIN 12; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; EXPRESSION VECTOR; GENE TRANSFER; HELPER CELL; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VIRUS IMMUNITY; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, VIRAL; DNA, RECOMBINANT; DNA, VIRAL; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; IMMUNITY, CELLULAR; LIVER; MICE; MICE, INBRED C57BL;

EID: 0029944988     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Straus SE. Adenovirus infections in humans. In: Ginsberg HS (ed). The Adenoviruses. Plenum Press: New York, 1984, pp 451-496.
2. Rosenfeld MA et al. Adenovirus-mediated transfer of a recombinant α1-antitrypsin gene to the lung epithelium in vivo. Science 1991; 252: 431-434.
3. Stratford-Perricaudet LD et al. Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Hum Gene Ther 1990; 1: 241-256.
4. Quantin B, Perricaudet LD, Tajbakhsh S, Mandel J-L. Adenovirus as an expression vector in muscle cells in vivo. Proc Natl Acad Sci USA 1992; 89: 2581-2584.
5. Rosenfeld MA et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 1992; 68: 143-155.
6. Zabner J et al. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 1993; 75: 207-216.
7. Crystal RG et al. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nat Genet 1994; 8: 42-51.
8. Jaffe H. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nature 1992; 1: 372-378.
9. Kay MA et al. In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs. Proc Natl Acad Sci USA 1994; 91: 2353-2357.
10. Ishibashi S et al. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 1993; 92: 883-893.
11. Kozarsky KF et al. In vwo correction of LDL receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J Biol Chem 1994; 269: 13695-13702.
12. Duncan S et al. Infection of mouse liver by human adenovirus type 5. J Gen Virol 1978; 40: 45-61.
13. Ginsberg H et al. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc Natl Acad Sci USA 1991; 88: 1651-1655.
14. Mullbacher A, Bellett A, Hla R. The marine cellular immune response to adenovirus type 5. Immunol Cell Biol 1989; 67: 31-39.
15. Yang Y, Ertl HCJ, Wilson JM. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1994; 1: 433-442.
16. Yang Y, Li Q, Ertl HCJ, Wilson JM. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 1995; 69: 2004-2015.
17. Dai Y et al. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor TX and vector antigens allows for long-term expression. Proc Natl Acad Sci USA 1995; 92: 1401-1405.
18. Zsengeller Z et al. Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice. Hum Gene Ther 1995; 6: 457-467.
19. Barr D et al. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Therapy 1995; 2: 151-155.
20. Yang Y et al. Immune responses to viral antigens vs transgene product in the elimination of recombinant adenovirus infected hepatocytes in vivo. Gene Therapy 1996; 3: 137-144.
21. Yei S et al. Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung. Gene Therapy 1994; 1: 192-200.
22. Smith TAG et al. Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nat Genet 1993; 5: 397-102.
23. Yang Y, Trinchieri G, Wilson JM. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung. Nat Med 1995; 1: 890-893.
24. van der Veen J, van Zaane DJ, Sprangers MAJ, Heyen CFA. Homotypic and heterotypic antibody response in infants to adenovirus vaccine. Arch Ges Virusforsch 1967; 21: 320-333.
25. Rowe WP, Hartley JW, Huebner RJ. Serotype composition of the adenovirus group. Proc Soc Exp Biol Med 1958; 97: 465-470.
26. + T cells in major histocompatibility complex class II-deficient mice. Science 1991; 253: 1417-1420.
27. + cytolytic T cells. Nature 1990; 344: 742-746.
28. Maraskovsky E, Chen W-F, Shortman K. IL-2 and IFN-γ are two necessary lymphokines in the development of cytotoxic T cells. J Immunol 1989; 143: 1210-1214.
29. Finkelman FD, Holmes J. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 1990; 8: 303-333.
30. Paul WE, Seder RA. Lymphocyte responses and cytokines Cell 1994; 76: 241-245.
31. Scott P. IL-12: Initiation cytokine for cell-mediated immunity. Science 1993; 260: 496-497.
32. Morris SC et al. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J Immunol 1994; 152: 1047-1056.
33. Yang Y et al. Cellular immunity to viral antigens limits El-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 1994; 91: 4407-4411.
34. Yang Y et al Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy for cystic fibrosis. Nat Genet 1994; 7: 362-369.